You may well be right if Hepalink and Eastern Capital are considered insiders for this deal.  Then the warrants are from Bloom Burton, Third Eye and other such entities are being talked about.  If Hepalink & Eastern Capital are insiders, then Third Eye etc. will be selling the shares into the market as they have zero interest in holding such assets in their balance sheet. 

In other words, the share price is capped at 1.33$ for now, in that scenario.